New Treatments for Childhood Neuroblastoma

NCI Pediatric In Vivo Testing Program: Neuroblastoma

NIH-funded research Children's Hosp of Philadelphia · NIH-11109481

This research aims to find better, personalized treatments for children with a serious type of cancer called neuroblastoma.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-11109481 on NIH RePORTER

What this research studies

Children with widespread neuroblastoma often face significant challenges with current treatments, so this project focuses on finding new solutions. Researchers are using models created from actual patient tumors, grown in mice, to test many different anti-cancer medicines. The goal is to understand the unique genetic features of each patient's neuroblastoma and use this information to develop targeted therapies. This approach helps identify the most promising new drugs that could eventually be used in clinical trials for children.

Who could benefit from this research

Good fit: This research focuses on understanding and treating neuroblastoma, particularly in children with widespread disease.

Not a fit: Patients without neuroblastoma would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to more effective and personalized treatments for children with neuroblastoma, improving their chances of cure.

How similar studies have performed: This program builds upon previous successful pediatric preclinical testing efforts, indicating a foundation of established methods.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.